The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro

Radiation Oncology

Volumn 1, Issue 1, 2006, Pages

  Rübel, Amelie ^a   Handrick, René ^a   Lindner, Lars H ^b   Steiger, Matthias ^b   Eibl, Hansjörg ^c   Budach, Wilfried ^d   Belka, Claus ^a   Jendrossek, Verena ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^d Department of Radiation Oncology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248400321     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-1-6     Document Type: Article

References (52)

1. Legler JM Ries LA Smith MA Warren JL Heineman EF Kaplan RS Linet MS Cancer surveillance series [corrected]: Brain and other central nervous system cancers: Recent trends in incidence and mortality J Natl Cancer Inst 1999 91 16 1382-1390 10.1093/jnci/91.16.1382 10451443
2. Shrieve DC Alexander E Black PM Wen PY Fine HA Kooy HM Loeffler JS Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: Prognostic factors and long-term outcome J Neurosurg 1999 90 1 72-77 http://www.thejns-net.org/jns/issues/v90n1/full/n0900072_fs.html 10413158
3. Seegenschmiedt MH Karlsson UL Black P Brady LW Thermoradiotherapy for brain tumors. Three cases of recurrent malignant astrocytoma and review of clinical experience Am J Clin Oncol 1995 18 6 510-518 8526195
4. Fine HA Dear KB Loeffler JS Black PM Canellos GP Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults Cancer 1993 71 8 2585-2597 8453582
5. Fumarola C Guidotti GG Stress-induced apoptosis: Toward a symmetry with receptor-mediated cell death Apoptosis 2004 9 1 77-82 10.1023/ B:APPT.0000012124.30095.09 14739601
6. Lowe SW Schmitt EM Smith SW Osborne BA Jacks T p53 is required for radiation-induced apoptosis in mouse thymocytes Nature 1993 362 6423 847-849 10.1038/362847a0 8479522
7. Miyashita T Reed JC Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 1995 80 2 293-299 10.1016/ 0092-8674(95)90412-3 7834749
8. Vousden KH Lu X Live or let die: The cell's response to p53 Nat Rev Cancer 2002 2 8 594-604 10.1038/nrc864 12154352
9. Oda E Ohki R Murasawa H Nemoto J Shibue T Yamashita T Tokino T Taniguchi T Tanaka N Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis Science 2000 288 5468 1053-1058 10.1126/science.288.5468.1053 10807576
10. Nakano K Vousden KH PUMA, a novel proapoptotic gene, is induced by p53 Mol Cell 2001 7 3 683-694 10.1016/S1097-2765(01)00214-3 11463392
11. Cory S Adams JM The Bcl2 family: Regulators of the cellular life-or-death switch Nat Rev Cancer 2002 2 9 647-656 10.1038/nrc883 12209154
12. Kolesnick R Fuks Z Radiation and ceramide-induced apoptosis Oncogene 2003 22 37 5897-5906 10.1038/sj.onc.1206702 12947396
13. von Haefen C Wieder T Gillissen B Starck L Graupner V Dorken B Daniel PT Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells Oncogene 2002 21 25 4009-4019 10.1038/sj.onc.1205497 12037683
14. Guner D Belka C Daniel PT Disruption of cell death signaling in cancer: impact on disease prognosis and response to therapy Curr Med Chem Anti-Canc Agents 2003 3 5 319-326 12871077
15. Lammering G Anti-epidermal growth factor receptor strategies to enhance radiation action Curr Med Chem Anti-Canc Agents 2003 3 5 327-333 12871078
16. Li J Yen C Liaw D Podsypanina K Bose S Wang SI Puc J Miliaresis C Rodgers L McCombie R Bigner SH Giovanella BC Ittmann M Tycko B Hibshoosh H Wigler MH Parsons R PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 1997 275 5308 1943-1947 10.1126/science.275.5308.1943 9072974
17. Haas-Kogan D Shalev N Wong M Mills G Yount G Stokoe D Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC Curr Biol 1998 8 21 1195-1198 10.1016/ S0960-9822(07)00493-9 9799739
18. Maher EA Furnari FB Bachoo RM Rowitch DH Louis DN Cavenee WK DePinho RA Malignant glioma: Genetics and biology of a grave matter Genes Dev 2001 15 11 1311-1333 10.1101/gad.891601 11390353
19. Belka C Jendrossek V Pruschy M Vink S Verheij M Budach W Apoptosis-modulating agents in combination with radiotherapy-current status and outlook Int J Radiat Oncol Biol Phys 2004 58 2 542-554 10.1016/j.ijrobp.2003.09.067 14751526
20. Jendrossek V Handrick R. Membrane targeted anticancer drugs: Potent inducers of apoptosis and putative radiosensitizers Curr Med Chem Anti-Cancer Agents 2003 3 5 343-353 12871080
21. Houlihan WJ Lohmeyer M Workman P Cheon SH Phospholipid antitumor agents Med Res Rev 1995 15 3 157-223 7658750
22. Berkovic D Grundel O Berkovic K Wildfang I Hess CF Schmoll HJ Synergistic cytotoxic effects of ether phospholipid analogues and ionizing radiation in human carcinoma cells Radiother Oncol 1997 43 3 293-301 10.1016/S0167-8140(97)01909-9 9215791
23. Georgieva MC Konstantinov SM Topashka-Ancheva M Berger MR Combination effects of alkylphosphocholines and gemcitabine in malignant and normal hematopoietic cells Cancer Lett 2002 182 2 163-174 10.1016/ S0304-3835(02)00088-5 12048162
24. Jendrossek V Kugler W Erdlenbruch B Eibl H Lang F Lakomek M Erucylphosphocholine-induced apoptosis in chemoresistant glioblastoma cell lines: Involvement of caspase activation and mitochondrial alterations Anticancer Res 2001 21 5 3389-3396 11848499
25. Ruiter GA Verheij M Zerp SF van Blitterswijk WJ Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis Int J Radiat Oncol Biol Phys 2001 49 2 415-419 10.1016/S0360-3016(00)01476-0 11173135
26. Stekar J Hilgard P Klenner T Opposite effect of miltefosine on the antineoplastic activity and haematological toxicity of cyclophosphamide Eur J Cancer 1995 31A 3 372-374 10.1016/0959-8049(94)00495-Q 7786605
27. Bruyneel EA Storme GA Schallier DC Van den Berge DL Hilgard P Mareel MM Evidence for abrogation of oncogene-induced radioresistance of mammary cancer cells by hexadecylphosphocholine in vitro Eur J Cancer 1993 29A 14 1958-1963 10.1016/0959-8049(93)90452-L 8280489
28. Ruiter GA Zerp SF Bartelink H van Blitterswijk WJ Verheij M Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis Cancer Res 1999 59 10 2457-2463 10344758
29. Jendrossek V Erdlenbruch B Hunold A Kugler W Eibl H Lakomek M Erucylphosphocholine, a novel antineoplastic ether lipid, blocks growth and induces apoptosis in brain tumor cell lines in vitro Int J Oncol 1999 14 1 15-22 9863004
30. Jendrossek V Hammersen K Erdlenbruch B Kugler W Krugener R Eibl H Lakomek M Structure-activity relationships of alkylphosphocholine derivatives: Antineoplastic action on brain tumor cell lines in vitro Cancer Chemother Pharmacol 2002 50 1 71-79 10.1007/s00280-002-0440-8 12111115
31. Erdlenbruch B Jendrossek V Gerriets A Vetterlein F Eibl H Lakomek M Erucylphosphocholine: Pharmacokinetics, biodistribution and CNS-accumulation in the rat after intravenous administration Cancer Chemother Pharmacol 1999 44 6 484-490 10.1007/s002800051122 10550569
32. Erdlenbruch B Jendrossek V Kugler W Eibl H Lakomek M Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats Cancer Chemother Pharmacol 2002 50 4 299-304 10.1007/s00280-002-0497-4 12357304
33. Jendrossek V Muller I Eibl H Belka C Intracellular mediators of erucylphosphocholine-induced apoptosis Oncogene 2003 22 17 2621-2631 10.1038/sj.onc.1206355 12730676
34. Belka C Budach W Anti-apoptotic Bcl-2 proteins: Structure, function and relevance for radiation biology Int J Radiat Biol 2002 78 8 643-658 10.1080/09553000210137680 12194748
35. Brown JM Wouters BG Apoptosis, p53, and tumor cell sensitivity to anticancer agents Cancer Res 1999 59 7 1391-1399 10197600
36. Belka C Schmid B Marini P Durand E Rudner J Faltin H Bamberg M Schulze-Osthoff K Budach W Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL Oncogene 2001 20 17 2190-2196 10.1038/sj.onc.1204318 11360204
37. Marini P Schmid A Jendrossek V Faltin H Daniel PT Budach W Belka C Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis BMC Cancer 2005 5 1 5 547906 15651986 10.1186/ 1471-2407-5-5
38. Tenzer A Zingg D Rocha S Hemmings B Fabbro D Glanzmann C Schubiger PA Bodis S Pruschy M The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C Cancer Res 2001 61 22 8203-8210 11719451
39. Magistrelli A Villa P Benfenati E Modest EJ Salmona M Tacconi MT Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver Drug Metab Dispos 1995 23 1 113-118 7720513
40. Unger C Sindermann H Peukert M Hilgard P Engel J Eibl H Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients Prog Exp Tumor Res 1992 34 153-159 1438798
41. Clive S Gardiner J Leonard RC Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma Cancer Chemother Pharmacol 1999 44 Suppl S29-30 http://www.springerlink.com/(qyc451am12hrewj25qqyssum)/ app/home/contribution.asp?referrer=parent&backto= ,328;linkingpublicationresults,1:100508,1 10.1007/s002800051114 10602908
42. Smorenburg CH Seynaeve C Bontenbal M Planting AS Sindermann H Verweij J Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients Anticancer Drugs 2000 11 10 825-828 10.1097/00001813-200011000-00006 11142690
43. Dummer R Krasovec M Roger J Sindermann H Burg G Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: Results of a phase I/II study J Am Acad Dermatol 1993 29 6 963-970 8245262
44. Leonard R Hardy J van Tienhoven G Houston S Simmonds P David M Mansi J Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer J Clin Oncol 2001 19 21 4150-4159 11689583
45. Sundar S Jha TK Thakur CP Engel J Sindermann H Fischer C Junge K Bryceson A Berman J Oral miltefosine for Indian visceral leishmaniasis N Engl J Med 2002 347 22 1739-1746 10.1056/NEJMoa021556 12456849
46. Hilgard P Klenner T Stekar J Nossner G Kutscher B Engel J D-21266, a new heterocyclic alkylphospholipid with antitumour activity Eur J Cancer 1997 33 3 442-446 10.1016/S0959-8049(97)89020-X 9155530
47. Van Ummersen L Binger K Volkman J Marnocha R Tutsch K Kolesar J Arzoomanian R Alberti D Wilding G A phase I trial of perifosine (NSC 639966) on a loading dose/maintenance dose schedule in patients with advanced cancer Clin Cancer Res 2004 10 22 7450-7456 10.1158/ 1078-0432.CCR-03-0406 15569974
48. Crul M Rosing H de Klerk GJ Dubbelman R Traiser M Reichert S Knebel NG Schellens JH Beijnen JH ten Bokkel Huinink WW Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours Eur J Cancer 2002 38 12 1615-1621 10.1016/S0959-8049(02)00127-2 12142051
49. Posadas EM Gulley J Arlen PM Trout A Parnes HL Wright J Lee MJ Chung EJ Trepel JB Sparreboom A Chen C Jones E Steinberg SM Daniels A Figg WD Dahut WL A Phase II Study of Perifosine in Androgen Independent Prostate Cancer Cancer Biol Ther 2005 4 10 16138006
50. Ernst DS Eisenhauer E Wainman N Davis M Lohmann R Baetz T Belanger K Smylie M Phase II Study of Perifosine in Previously Untreated Patients with Metastatic Melanoma Invest New Drugs 2005 16034524
51. Konstantinov SM Berger MR Human urinary bladder carcinoma cell lines respond to treatment with alkylphosphocholines Cancer Lett 1999 144 2 153-160 10.1016/S0304-3835(99)00219-0 10529015
52. Berenbaum MC A method for testing for synergy with any number of agents J Infect Dis 1978 137 2 122-130 627734